Lv3
300 积分 2025-03-05 加入
Next-generation therapeutics for diabetic kidney disease
1个月前
已完结
Acarbose ameliorates podocyte injury and glomerular lesions in diabetic nephropathy through USP46 activation
1个月前
已完结
Exploring the nephroprotective effects of combined finerenone and exenatide therapy in diabetic nephropathy
1个月前
已完结
Edaravone dexborneol versus placebo on functional outcomes in patients with acute ischaemic stroke undergoing endovascular thrombectomy (TASTE-2): randomised controlled trial
3个月前
已关闭
Two drugs are better than one to start T2DM therapy
4个月前
已完结
Superior efficacy of empagliflozin and finerenone combination therapy versus monotherapy in patients with CKD and T2DM
4个月前
已关闭
Chinese patent medicine as a complementary and alternative therapy for type 2 diabetes mellitus: A scoping review
5个月前
已完结
Quercetin prevented diabetic nephropathy by inhibiting renal tubular epithelial cell apoptosis via the PI3K/AKT pathway
5个月前
已完结
Swietenine improved the progression of diabetic nephropathy through inhibiting ferroptosis via activating Akt/GSK-3β/Nrf2 signaling pathway
6个月前
已完结
皖公网安备34019202002308
